tiprankstipranks
Trending News
More News >
Revolution Medicines (RVMD)
NASDAQ:RVMD
US Market

Revolution Medicines (RVMD) Income Statement

Compare
583 Followers

Revolution Medicines Income Statement

Last quarter (Q3 2025), Revolution Medicines's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Revolution Medicines's net income was $-305.21M. See Revolution Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 11.58M$ 35.38M$ 29.39M$ 42.98M
Gross Profit
$ 0.00$ 11.58M$ 35.38M$ 29.39M$ 42.98M
Operating Expenses
$ 689.52M$ 498.76M$ 293.66M$ 217.40M$ 153.68M
Depreciation and Amortization
$ 11.82M$ 9.31M$ 9.66M$ 7.33M$ 6.54M
EBITDA
$ -677.70M$ -477.88M$ -248.62M$ -179.75M$ -101.91M
Operating Income
$ -689.52M$ -487.19M$ -258.28M$ -188.01M$ -110.70M
Other Income/Expenses
$ 88.68M$ 47.29M$ 9.15M$ 917.00K$ 2.17M
Pretax Income
$ -600.85M$ -439.89M$ -249.13M$ -187.09M$ -108.53M
Net Income
$ -600.09M$ -436.37M$ -248.71M$ -187.09M$ -108.16M
Per Share Metrics
Basic EPS
$ -3.58$ -3.86$ -3.08$ -2.47$ -1.62
Diluted EPS
$ -3.58$ -3.86$ -3.08$ -2.47$ -1.62
Weighted Average Shares Outstanding
167.74M 113.15M 80.63M 72.81M 66.60M
Weighted Average Shares Outstanding (Diluted)
167.74M 113.15M 80.63M 72.81M 66.60M
Currency in USD

Revolution Medicines Earnings and Revenue History